Abiopharma

NEUPATH HEALTH REPORTS SECOND QUARTER 2026 RESULTS

NervGen Reports Second Quarter 2026 Financial Results and Provides Business Updates

Abeona Therapeutics® Reports Second Quarter 2026 Results and Provides Business Update

MiNK Therapeutics Reports Second Quarter 2026 Financial Results and Reports Observations from Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury

Indonesia Energy Corporation Reports Progress on Drilling of K-29 Well

Bragg Gaming Group Reports Second Quarter 2026 Financial Results

Cormedix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Cabaletta Bio Reports Second Quarter 2026 Financial Results and Provides Business Update

Sprinklr Appoints Jordi Ribas to Board of Directors

DEFSEC Technologies Inc. Announces Third Quarter Fiscal 2026 Results

UTStarcom Announces Finance Leadership Changes

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0000950103-26-012291 <b>Size:</b> 83 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023654 <b>Size:</b> 614 KB

New Form SCHEDULE 13G/A - Genpact LTD <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001167557-26-000188 <b>Size:</b> 8 KB

Asset Acquisitions and Disposals: ANNOUNCEMENT PURSUANT TO RULE 706A OF THE LISTING MANUAL